Prothena Corp Public (PRTA) Revenue Growth (5y) (2017 - 2026)
Prothena Corp Public (PRTA) Revenue Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Prothena Corp Public | 469.41 Mn | 139.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216.83% |
| Dec 31, 2025 | -43.35% |
| Sep 30, 2025 | 72.74% |
| Jun 30, 2025 | 86.67% |
| Mar 31, 2025 | 82.16% |
| Dec 31, 2024 | 52.67% |
| Sep 30, 2024 | 36.46% |
| Jun 30, 2024 | 279.82% |
| Mar 31, 2024 | -23.11% |
| Dec 31, 2023 | 10.25% |
| Sep 30, 2023 | 219.48% |
| Jun 30, 2023 | 70.49% |
| Mar 31, 2023 | 57.05% |
| Dec 31, 2022 | 193.56% |
| Sep 30, 2022 | 47.27% |
| Jun 30, 2022 | -45.31% |
| Mar 31, 2022 | 34.80% |
| Dec 31, 2021 | 46.96% |
| Sep 30, 2021 | 244.70% |
| Jun 30, 2021 | 182.65% |